No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC)

Epidermal growth factor receptor (EGFR) is usually expressed in squamous cell anal carcinoma (SCAC) and anti-EGFR agents could represent a valid treatment strategy, also considering that KRAS and BRAF mutations are rare events in this type of cancer. However, no data are available on NRAS status in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Capelli, Laura, Casadei Gardini, Andrea, Scarpi, Emanuela, Frassineti, Giovanni Luca, Saragoni, Luca, Puccetti, Maurizio, Scartozzi, Mario, Giannini, Massimo, Tamberi, Stefano, Corbelli, Jody, Ulivi, Paola
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122846/
https://ncbi.nlm.nih.gov/pubmed/27886225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep37621
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia